The law aims to supply cannabis to seriously ill patients who have any one of 17 qualifying ailments. It was an easy sell for the conservative legislature: Polling found that nearly 9 out of 10 Pennsylvanians approved of medical marijuana, which already is legal in some other states, including New Jersey. Also, the law prohibits the drug from being made available in dry leaf or plant form only in pill, oil, gel, vapor or liquid forms. Thea la carte permits to be doled out in the months ahead represent only the first Green Rush phase of a frenzied bidding process. The state also is preparing to offer what one industry insider called a ” Godzilla License .” That credential would allow eight academic medical centers to select investor partners to establish research, growing and dispensary networks of their own. Health systems have been soliciting potential suitors for months. Just one of those “clinical registrant” permits could be worth as much as $50 million on the day of issue,said Troy Kaplan , a New Jersey attorney who specializes in medical cannabis law and is advising clients in Pennsylvania. Each of those permits packs a punch by bundling the right to grow and process marijuana, conduct research under the auspices of a medical school, and operate up to six dispensaries, Kaplan said. People across the wealth and professional spectrum are angling for a way in, according to attorney Mark L. Alderman , chairman of Cozen OConnor Public Strategies , whose firm is working with unnamed clients seeking medical marijuana permits. Private equity, pharma execs, out-of-state-operators, entrepreneurs, pharmacists, farmers, Alderman said.